Lori Kautzman, MD
Transplant Surgery · Dallas, TXNPI 1962555888
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Intuitive Surgical at 57.6% of the total. Reporting peaked in 2021 at $4,077 and has fallen 86.7% since, to $542 in 2025.
Across 106 payments — averaging $61.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$833
- Transmedics, Inc.$439
- Xvivo Perfusion Inc.$332
- Intercept Pharmaceuticals, Inc.$308
- Haemonetics Corporation$135
- plus $722 from 14 others
What the payments were for
- Travel & lodging$1,08117%
- Food & beverage$2,45238%
- Education$3,00046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $3,763 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 50 | $833 |
| Transmedics, Inc. | 1 | $439 |
| Xvivo Perfusion Inc. | 1 | $332 |
| Intercept Pharmaceuticals, Inc. | 16 | $308 |
| Haemonetics Corporation | 1 | $135 |
| Eisai Inc. | 5 | $113 |
| AbbVie | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Hemosonics LLC | 1 | $66 |
| Merck | 2 | $64 |
| Dynavax Technologies Corporation | 3 | $56 |
| VBI Vaccine (delaware) Inc. | 2 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Laborie Medical Technologies Corp. | 1 | $38 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Novo Nordisk | 1 | $17 |
| Eton Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,532 in reported general payments places this provider in the 70th percentile of 70 transplant surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 21 | $70 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Dallas
- Goran KlintmalmDallas$88K
- Alejandro MejiaDallas$20K
- Richard RuizDallas$16K
- Christie GoodenDallas$8K
- Steven HanishDallas$7K
- Jason SchwartzDallas$5K
- Tiffany AnthonyDallas$5K
- Anji WallDallas$4K
- Gregory McKennaDallas$4K
- Seung Hee LeeDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.